Newsroom

News

published at: 03.02.2025

World Cancer Day on February 4: From shadow to light

With the exhibition "From Shadow to Light", six master students from the Dresden University of Fine Arts (HfBK Dresden) approached these questions in 2023/24. After the works by Eric Beier, Noemi Durighello, Hanne Lange, Michael Merkel, Julia Schmelzer and Tillmann Ziola have been on display at the NCT/UCC Dresden for a year, the exhibition will go on tour from February 4. It will initially be on display for almost four weeks at Dresden's Altmarkt-Galerie.
Read More…
World Cancer Day on February 4: From shadow to light

published at: 18.12.2024

RATIONALE focuses on rare cancers: First multi-site study by the National Center for Tumor Diseases (NCT)

Recruitment for RATIONALE will begin at the NCT in 2025. The study is investigating the benefits of molecularly controlled treatment for patients with rare cancers. The researchers want to prove that the progression-free survival of patients with advanced rare cancers can be doubled compared to standard therapy. For the first time, all six NCT sites are pooling their joint expertise in a study involving patients throughout Germany.
Read More…
RATIONALE focuses on rare cancers: First multi-site study by the National Center for Tumor Diseases (NCT)

published at: 05.11.2024

ERC Synergy Grant for ClonEScape: Tracking the development of tumors

A research alliance from Cambridge (Great Britain), Daejeon (South Korea) and Dresden is working to shed some light on the origin of clonal pathogenesis with the joint project "ClonEScape". For this project, the scientists Prof. Benjamin Simons (University of Cambridge), Dr. Maria Alcolea (University of Cambridge), Dr. Bon-Kyoung Koo (Institute for Basic Science) and Prof. Daniel Stange (TU Dresden) have been awarded the prestigious Synergy Grant of the European Research Council (ERC) alongside funding amounting to almost EUR 10M.
Read More…
ERC Synergy Grant for ClonEScape: Tracking the development of tumors

published at: 02.10.2024

Dresden researchers receive funding award for developing AI models for leukemia detection in bone marrow

Digitalization is playing an increasingly important role in laboratories as well. The use of artificial intelligence in data analysis significantly expands possibilities in the areas of diagnostics and individualized therapies. Therefore, the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) awards the Digital Laboratory Funding Prize for outstanding scientific achievements.
Read More…
Dresden researchers receive funding award for developing AI models for leukemia detection in bone marrow

published at: 18.09.2024

New imaging procedures in cancer surgery: Helmholtz High Impact Award for Oliver Bruns and Ellen Sletten

18.09.2024: Biochemist Oliver Bruns (NCT/UCC Dresden) and chemist Ellen Sletten (UCLA) have been presented with the Helmholtz High Impact Award 2024 by the Helmholtz Association and the “Stifterverband für die Deutsche Wissenschaft” for their research into an innovative medical imaging technology in the short-wave infrared range. The procedure they have developed has the potential to significantly improve surgical removal of tumors. At yesterday’s award ceremony in Berlin, the two scientists were presented with the award – endowed with € 50,000 – in recognition of their interdisciplinary research.
Read More…

published at: 30.08.2024

NCT/UCC Dresden: Millions in funding from the Chan Zuckerberg Initiative for state-of-the-art imaging to accurately detect minute tumors

30.08.2024: An international group of scientists led by Prof. Oliver Bruns (NCT/UCC Dresden), Dr. Andriy Chmyrov (NCT/UCC Dresden), Prof. Ellen Sletten (UCLA) and Prof. Christopher Rowlands (Imperial College London) has once again received renowned funding from the Chan Zuckerberg Initiative. With their research, the team strives to improve imaging in deeper tissue layers.
Read More…